164 related articles for article (PubMed ID: 16908426)
21. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
22. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.
Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC
J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564
[TBL] [Abstract][Full Text] [Related]
23. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
[TBL] [Abstract][Full Text] [Related]
24. Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts.
Tian F; Sandler N; Aaltonen J; Lang C; Saville DJ; Gordon KC; Strachan CJ; Rantanen J; Rades T
J Pharm Sci; 2007 Mar; 96(3):584-94. PubMed ID: 17080412
[TBL] [Abstract][Full Text] [Related]
25. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
26. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution.
Bolourchian N; Talamkhani Z; Nokhodchi A
Pharm Dev Technol; 2019 Nov; 24(9):1115-1124. PubMed ID: 31282827
[TBL] [Abstract][Full Text] [Related]
27. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
[TBL] [Abstract][Full Text] [Related]
29. Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet.
Lee H; Park SA; Sah H
Arch Pharm Res; 2005 Jan; 28(1):120-6. PubMed ID: 15742820
[TBL] [Abstract][Full Text] [Related]
30. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
Thongnopkoon T; Puttipipatkhachorn S
Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
[TBL] [Abstract][Full Text] [Related]
31. Effect of crospovidone and hydroxypropyl cellulose on carbamazepine in high-dose tablet formulation.
Flicker F; Betz G
Drug Dev Ind Pharm; 2012 Jun; 38(6):697-705. PubMed ID: 22010838
[TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro study of six carbamazepine products.
Mittapalli PK; Suresh B; Hussaini SS; Rao YM; Apte S
AAPS PharmSciTech; 2008; 9(2):357-65. PubMed ID: 18431676
[TBL] [Abstract][Full Text] [Related]
33. Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate.
Greco K; Bogner R
AAPS PharmSciTech; 2011 Sep; 12(3):909-16. PubMed ID: 21732157
[TBL] [Abstract][Full Text] [Related]
34. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.
Katzhendler I; Azoury R; Friedman M
J Control Release; 2000 Apr; 65(3):331-43. PubMed ID: 10699292
[TBL] [Abstract][Full Text] [Related]
35. Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers.
Omori M; Yamamoto H; Matsui F; Sugano K
Pharm Res; 2023 Feb; 40(2):579-591. PubMed ID: 35194718
[TBL] [Abstract][Full Text] [Related]
36. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance.
Ullah M; Hussain I; Sun CC
Drug Dev Ind Pharm; 2016; 42(6):969-76. PubMed ID: 26460090
[TBL] [Abstract][Full Text] [Related]
37. Variability in commercial carbamazepine samples--impact on drug release.
Flicker F; Eberle VA; Betz G
Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
[TBL] [Abstract][Full Text] [Related]
38. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
[TBL] [Abstract][Full Text] [Related]
39. Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms.
Liu C; Chen Z; Chen Y; Lu J; Li Y; Wang S; Wu G; Qian F
Mol Pharm; 2016 Feb; 13(2):599-608. PubMed ID: 26709621
[TBL] [Abstract][Full Text] [Related]
40. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
Dave RH; Patel AD; Donahue E; Patel HH
Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
